Company currently on track to hit net leverage target range of 2.0x – 2.5x by 2026 Guidance for 2025 re-affirmed; adjusted EBITDA expected to be at the middle to higher end of the range Capitalized ...
Enabled ECG Diagnostics to Address the Growing Cardiovascular Disease Burden in Jamaica TORONTO, ON / ACCESS Newswire / November 4, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback